angiotensin ii, des-phe(8)- has been researched along with Diabetes Mellitus, Type 1 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Ren, Y; Sheng, S; Wu, D; Xie, W; Yang, S; Zhang, H | 1 |
| Franklin, R; Kuipers, A; Moll, GN; Wagner, E | 1 |
| Chan, JS; Chenier, I; Filep, JG; Ingelfinger, JR; Lo, CS; Maachi, H; Shi, Y; Zhang, SL | 1 |
| de Oliveira, AM; Gomes, MS; Pernomian, L; Restini, CB | 1 |
| Jarajapu, YP; Pawar, R; Singh, N; Vasam, G | 1 |
| Akhtar, S; Benter, IF; El-Hashim, AZ; Makki, B; Yousif, MH | 1 |
| Cosic, A; Drenjancevic, I; Falck, JR; Kibel, A; Mihaljevic, Z; Novak, S | 1 |
| Abdo, S; Chan, JS; Chenier, I; Filep, JG; Ingelfinger, JR; Lo, CS; Padda, R; Shi, Y; Zhang, SL | 1 |
| Chen, YG; Hao, PP; Yang, JM; Zhang, C; Zhang, K; Zhang, MX; Zhang, Y | 1 |
| Aragão, DS; Arita, DY; Bertoncello, N; Casarini, DE; Cunha, TS; Dantas, PS; Mattar-Rosa, R; Moreira, RP; Santos, R; Watanabe, IK; Yokota, R | 1 |
| Akhtar, S; Attur, S; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH | 1 |
| Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH | 1 |
| Debnam, ES; Ho, KY; Leung, PS; Ng, EK; Wong, TP | 1 |
13 other study(ies) available for angiotensin ii, des-phe(8)- and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
OIP5-AS1 Attenuates Microangiopathy in Diabetic Mouse by Regulating miR-200b/ACE2.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Caspase 3; Cognition; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Gene Knockdown Techniques; Hippocampus; Maze Learning; Mice; Mice, Knockout; MicroRNAs; Peptide Fragments; Peptidyl-Dipeptidase A; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Long Noncoding | 2020 |
Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models.
Topics: Alanine; Angiotensin I; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Insulin; Mice; Mice, Inbred C57BL; Peptide Fragments; Streptozocin; Sulfides; Treatment Outcome | 2019 |
Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.
Topics: Albuminuria; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Apoptosis; Catalase; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fibrosis; Hypertension; Kidney; Kidney Tubules; Kidney Tubules, Proximal; Male; Mice; Mice, Transgenic; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A | 2013 |
MAS-mediated antioxidant effects restore the functionality of angiotensin converting enzyme 2-angiotensin-(1-7)-MAS axis in diabetic rat carotid.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Blood Flow Velocity; Carotid Arteries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydrogen Peroxide; Male; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2014 |
Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.
Topics: Angiotensin I; Animals; Bone Marrow Cells; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Flow Cytometry; Male; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Penis; Peptide Fragments; Proto-Oncogene Mas; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2014 |
Chronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetes.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Body Weight; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Erectile Dysfunction; Male; Penis; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; rho-Associated Kinases; Streptozocin | 2014 |
Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme Induction; Enzyme Inhibitors; Hyperbaric Oxygenation; Male; Oxidative Stress; Peptide Fragments; Rats, Sprague-Dawley; Steroid 16-alpha-Hydroxylase; Vascular Resistance; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |
Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Type 1; Fibrosis; Gene Expression Regulation; Histological Techniques; Hypertension; Immunohistochemistry; Injections, Subcutaneous; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled | 2015 |
Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
Topics: Angiotensin I; Animals; Blood Glucose; Cells, Cultured; Coculture Techniques; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Fibrosis; Heart Ventricles; Lipids; Male; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Time Factors; Transforming Growth Factor beta1; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2015 |
Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.
Topics: Angiotensin I; Animals; Blood Glucose; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Dosage; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Kidney; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Spectrometry, Fluorescence | 2015 |
Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
Topics: Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; ErbB Receptors; Gene Expression Regulation; Glucose; Male; Muscle, Smooth, Vascular; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Transcriptional Activation; Vasodilator Agents | 2015 |
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury | 2012 |
Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Biological Transport; Caco-2 Cells; Cells, Cultured; Diabetes Mellitus, Type 1; Enterocytes; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; In Vitro Techniques; Injections, Intravenous; Jejunum; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; RNA, Messenger; Up-Regulation | 2012 |